Poraive IV infusion 140mg from Chugai Pharmaceutical contains Polatuzumab vedotin (genetical recombination), an antibody-drug conjugate. It targets CD79b on B-cells, inhibiting cell division and promoting apoptosis for the treatment of diffuse large B-cell lymphoma. This injectable drug is available as 140mg per bottle, with YJ code 4291455D2029.
Poraive IV infusion 140mg
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →